Lornoxicam

氯诺昔康

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLornoxicam
Drug Alias NameChlortenoxicam氯诺西康药药昔康TaigalorXefo +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsFractures, ClosedHeadacheLow Back Pain +[12] 
Global Approved IndicationsLow Back PainPainPain, Postoperative +[9] 
Approved Indications in ChinaPainPain, PostoperativeNeuralgia +[5] 
Original Approved Country/TerritoryDenmark
Original Approved Date1997/01/01
Country/TerritoryUnited StatesDenmarkEgypt +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNycomed Austria GmbhTaisho Pharmaceutical Holdings Co Ltd
Inactive CompaniesMansoura UniversityAutobahn Therapeutics Inc
Active IndicationsLow Back PainPainPain, Postoperative +[9] 
Inactive IndicationsFractures, ClosedHeadacheMigraine Disorders

Other Information

ATC CodeM01AC05
Related LinksWikipediaDrugBankKEGG